How Tilray-MedMen deal could impact either cannabis company’s US aspirations
Last week, British Columbia-based Tilray (TLRY on Nasdaq, TSX), the second-largest Canadian licensed producer by market cap, announced…
News August 25
Latest In: Tilray
With an eye on US cannabis market, Canadian firm Tilray acquires majority of MedMen debt
Tilray said Tuesday it acquired a majority of the debt that California-based MedMen Enterprises owes to New York…
News August 17
Tilray reports $336M annual loss, targets $4B in cannabis sales by 2024
Canadian cannabis producer Tilray reported an annual loss of $336 million (422 million Canadian dollars) for its fiscal…
News July 28
Medical cannabis grown in Germany available for first time
German-grown medical cannabis is available for purchase and sale by local pharmacies for the first time, the Federal…
News July 7
Canadian cannabis firm Aphria gave CEO $8.1 million to become full-time employee
Canadian cannabis producer Aphria gave then-CEO Irwin Simon a cash and stock compensation package worth $8.1 million (10.5…
News June 30
Cannabis firm Tilray reports $341 million net loss in last stand-alone quarter
Tilray’s recreational and medical cannabis revenue plunged in the final quarter before its merger with Aphria went into…
News May 11
Tilray, Aphria complete blockbuster marijuana merger
Once-rival cannabis producers Tilray and Aphria completed their megamerger, the new company announced Monday, forming one of the…
News May 3
Cannabis firm Tilray reduces minimum quorum after delayed investor meeting
British Columbia-based Tilray amended its bylaws to reduce the required quorum for shareholder meetings, the cannabis producer said…
News April 16
Cannabis producer Tilray postpones shareholder vote on Aphria merger
Canadian cannabis producer Tilray postponed a special shareholder meeting to vote on its proposed megamerger with Aphria. The…
News April 15Featured
1
Latest Sponsored
